Chatham Capital Group, Inc.
Source: SEC Form 13F · as of Mar 2026Chatham Capital Group, Inc. holds 10 biotech & pharma companies tracked by BioSniper, totaling $33.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$33.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 34,427 | $8.4M |
| LLYELI LILLY & Co | 9,118 | $8.4M |
| ABBVAbbVie Inc. | 26,211 | $5.7M |
| MRKMerck & Co., Inc. | 45,959 | $5.5M |
| ABTABBOTT LABORATORIES | 23,330 | $2.4M |
| BMYBRISTOL MYERS SQUIBB CO | 21,545 | $1.3M |
| PFEPFIZER INC | 28,750 | $807K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,391 | $647K |
| AMGNAMGEN INC | 899 | $316K |
| PMPhilip Morris International Inc | 1,826 | $302K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.